HK Stock Connect Daily Report: Hong Kong Banking Sector Proposes Adding "IPO Connect" to "Stock Connect"; ZHIDA TECH Retraces More Than 30% - 20260911

NewTimeSpace · 2026/09/11 18:09 · By Zeyu Wu

On September 11, 2026, the three major Hong Kong stock indices opened lower and moved in a choppy range, with the Hang Seng Index down 0.60%, the Hang Seng Tech Index down 0.23%, and the Hang Seng China Enterprises Index down 0.34%. Total turnover of the Hang Seng Index market for the full day was HK$228.4 billion. DAJIN rose 10.78%, as the shipbuilding sector sees a highly prosperous order intake and European offshore wind tenders are expected to form a catalyst; ZHIDA TECH, which surged yesterday, retraced 31.77%, with turnover of HK$1.147 billion.

I. Market Overview

On the board, among Stock Connect constituent stocks, CHERVON surged 23.00% as the company appointed a former senior executive of TECHTRONIC IND as chief executive officer; TYK MEDICINES-B rose 11.38%, as the chairman increased his shareholding, demonstrating confidence in long-term development, and an innovative EGFR-TKI won blockbuster approval; DAJIN rose 10.78%, as the shipbuilding sector sees a highly prosperous order intake and European offshore wind tenders are expected to form a catalyst; ZHIDA TECH, which surged yesterday, retraced 31.77%, with turnover of HK$1.147 billion.

Southbound capital recorded net buying of HK$4.431 billion on the day. Of this, Stock Connect (Shanghai) recorded net buying of HK$3.192 billion, and Stock Connect (Shenzhen) recorded net buying of HK$1.239 billion.

II. HK Stock Connect Stock Rankings

2.1 HK Stock Connect Stock Gainers and Decliners

Category	Stock Code	Stock Name	Change (%)	Close (HKD)	Turnover (HKD 100mn)
Gainers No. 1	01021.HK	HUAYAN ROBOTICS	25.62	11.890	11.38
Gainers No. 2	02285.HK	CHERVON	23.00	24.600	4.56
Gainers No. 3	01440.HK	STAR SHINE HLDG	22.83	14.040	1.39
Gainers No. 4	02729.HK	GALAXIS TECH	17.64	42.420	2.33
Gainers No. 5	06675.HK	SENASIC	11.19	31.000	0.23
Decliners No. 5	00358.HK	JIANGXI COPPER	-9.19	34.960	12.67
Decliners No. 4	01879.HK	XIZHI TECH-P	-9.87	312.400	1.84
Decliners No. 3	07666.HK	METIS TECHBIO-P	-11.38	15.420	2.39
Decliners No. 2	02889.HK	PATEO	-12.68	87.100	0.68
Decliners No. 1	02650.HK	ZHIDA TECH	-31.77	10.180	11.47

Source: Wind, HKEX. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

2.2 HK Stock Connect Active Stocks (ranked by southbound turnover)

Rank	Stock Code	Stock Name	Southbound Turnover (HKD 100mn)	Southbound Net Buy (HKD 100mn)	Change (%)
1	06869.HK	YOFC	52.97	4.21	3.44
2	02513.HK	Z.AI	39.67	4.57	-3.17
3	00100.HK	MINIMAX-W	31.13	-0.96	-7.53
4	01888.HK	KB LAMINATES	27.67	2.90	-1.48
5	00700.HK	TENCENT	25.96	2.07	0.66
6	03308.HK	ZJ INNOLIGHT	25.25	6.48	4.37
7	00981.HK	SMIC	21.09	-1.71	-0.47
8	00883.HK	CNOOC	20.03	-0.17	-2.56
9	06166.HK	CIG	13.08	0.52	-2.35
10	02685.HK	QUANTGROUP	11.59	0.08	3.83

III. HK Stock Connect-related A-share ETF Rankings

3.1 HK Stock Connect-related A-share ETF Gainers and Decliners

Category	Code	Short Name	Change (%)	Turnover (RMB 100mn)
Gainers No. 1	520870	E Fund Itaú Unibanco IBOVESPA ETF(QDII)	1.97	1.68
Gainers No. 2	159100	ChinaAMC Bradesco Brazil Ibovespa ETF(QDII)	1.20	0.88
Gainers No. 3	159179	ICBCCS CSI HK Equities Internet ETF	0.78	0.16
Gainers No. 4	520650	China Southern CSI HK Equities Internet ETF	0.71	0.60
Gainers No. 5	520740	Huaan CSI HK Equities Internet ETF	0.70	0.01
Decliners No. 5	513000	E Fund Amova NKY ETF(QDII)	-2.08	1.69
Decliners No. 4	513880	Huaan MAXIS NKY ETF(QDII)	-2.08	1.87
Decliners No. 3	513310	Huatai-PB China Securities Han Stock Exchange China Korea Semiconductor ETF(QDII)	-2.19	83.65
Decliners No. 2	520880	Hwabao WP Hang Seng HK Innovative Drugs Selected ETF	-2.26	1.49
Decliners No. 1	159567	Yinhua CNI HK Equities Innovative Drugs ETF	-2.36	5.25

Source: Wind. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

3.2 HK Stock Connect-related A-share ETF Active Rankings (ranked by turnover)

Rank	Code	Short Name	Tracking Index	Turnover (RMB 100mn)	Turnover Rate (%)	Change (%)
1	513310	Huatai-PB China Securities Han Stock Exchange China Korea Semiconductor ETF(QDII)	China-Korea Semiconductor	83.65	71.68	-2.19
2	513120	GF CSI HK Innovative Drugs Industry ETF(QDII)	HK Innovative Drugs in HKD	35.66	15.85	-1.76
3	513090	E Fund CSI Hong Kong Securities Investment Theme ETF	Hong Kong Securities in HKD	25.56	14.51	-1.95
4	513180	ChinaAMC Hang Seng Technology ETF(QDII)	Hang Seng Tech Index	21.26	5.57	-0.36
5	513130	Huatai-PB CSOP Hang Seng Technology Index ETF(QDII)	Hang Seng Tech Index	19.42	6.08	0.19
6	513330	ChinaAMC Hang Seng Internet Technology Industry ETF(QDII)	Hang Seng Internet Technology Industry Index	14.41	5.74	0.00
7	513050	E Fund CSI Overseas China Internet 50 ETF	CSI Overseas China Internet 50 Index in RMB	14.00	4.01	0.50
8	159570	China Universal CNI HK Equities Innovative Drugs ETF	HK Equities Innovative Drugs	13.79	6.78	-1.79
9	513350	Fullgoal S&P Oil & Gas Exploration and Production Selected Industry ETF(QDII)	S&P Oil & Gas Exploration & Production Select Industry	13.23	109.61	-1.77
10	159792	Fullgoal CSI HK Equities Internet ETF	HK Equities Internet	10.45	3.11	0.37

IV. Industry and Corporate Updates

1、Changes to Hang Seng Biotech Index Constituents to Be Implemented After Today's Market Close, Effective September 14

The results of Hang Seng Indexes Company's quarterly review show that the Hang Seng Biotech Index will include DIAGENS-B (02526) and remove HUTCHMED (00013), with the number of constituent stocks maintained at 30. The change will be implemented after the market close on September 11, 2026 (Friday) and will take effect from September 14 (Monday), later than the effective date of September 7 for the Hang Seng Index, the Hang Seng Tech Index and the Hang Seng Composite Index. In addition, Hang Seng Indexes Company will implement a change in the calculation method of the index from September 14: due to changes in the Hang Seng industry classification, the industry requirements for index eligibility have been updated to five business sub-categories, namely "Pharmaceuticals", "Biotechnology", "Pharmaceutical Distribution", "Pharmaceutical and Biotechnology Contract Services" and "Medical Devices and Supplies", while the index name and code remain unchanged.

2、GENSCRIPT BIO Places 77.126 Million Shares, Raising Approximately HK$2.3271 Billion Net

On the morning of September 11, GENSCRIPT BIO (01548) announced that the company had entered into a placing agreement with a placing agent, proposing to place 77.126 million new shares at a placing price of HK$30.50 per share, a discount of approximately 4.7% to the closing price of HK$32.00 on September 10, with the placed shares accounting for approximately 3.50% of the issued share capital as of the date of the announcement. Gross proceeds are expected to be approximately HK$2.3523 billion, with net proceeds of approximately HK$2.3271 billion and a net issue price of approximately HK$30.17 per share. As for the use of proceeds, approximately 70% will be used to expand the production capacity and infrastructure of the AIDD platform, including automated high-throughput wet laboratory facilities, related equipment and laboratory upgrades; approximately 20% will be used for related R&D, digital workflow integration and global business expansion; and approximately 10% will be used for general corporate purposes and working capital. The placing is expected to be completed on September 15.

3、HENGRUI PHARMA Discloses Progress on Two Products, with a New Indication Approved for a Class 1 Innovative Drug

HENGRUI PHARMA (01276) announced several R&D developments: the company's self-developed Class 1 innovative drug hetrombopag olamine tablets were approved for two additional indications; in the same period, the marketing authorization application for retatrutide injection was accepted by the National Medical Products Administration. The two developments correspond respectively to the indication expansion of an already marketed product and the registration filing stage of a pipeline product.

4、Hong Kong Banking Sector Proposes Adding "IPO Connect" to "Stock Connect", Allowing Mainland Investors to Participate in Hong Kong IPOs

On September 11, The Hong Kong Association of Banks and Deloitte China jointly released the "Hong Kong Banking 2030" report, proposing to further deepen financial connectivity between Hong Kong and the mainland by extending the mutual market access framework to an IPO Connect, allowing mainland investors to participate in Hong Kong IPOs. In 2026, HKEX introduced an optimized "first-day inclusion in Stock Connect" arrangement; shares eligible for "first-day inclusion in Stock Connect" are limited to A+H dual-listed companies and require voluntarily giving up the greenshoe mechanism (over-allotment option). The report also proposes accelerating the inclusion of RMB-denominated trading counters in mutual market access, allowing mainland investors to buy and sell Hong Kong-listed shares in RMB. The "IPO Connect" is still at the stage of industry advocacy and study.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

NewTimeSpace HK Stock Connect HK Stock Connect ETF